Clinical Trial Update: Safety,Tolerability and Immunogenicity of Vaccination With VARIVAX in Healthy Indian Children (V210-056) [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the safety, tolerability, and immunogenicity of the VARIVAX varicella vaccine in healthy Indian children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Varicella

Drugs mentioned

• Varivax (varicella vaccine (live attenuated))

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Varicella | Phase 3 | Status: COMPLETED